Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

An open-label, multicenter Extension study to evaluate the safety and tolerability of RANIBIZUMAB in subjects with choroidal neovascularization (CNV) secondary to age related macular degeneration (AMD) or macular edema secondary to RETINAL VEIN OCCLUSION (RVO) who have completed a genentech sponsored RANIBIZUMAB STUDY
ranibizumab
FVF3426G
cohort 1 - NCT00379795
cohort 2 - NCT01442064
Neovascular Age-related Macular Degeneration
Phase 3
 
December 2015

Powered by ideaPoint, Inc.